15
Participants
Start Date
July 12, 2022
Primary Completion Date
January 31, 2027
Study Completion Date
January 31, 2027
Cenobamate
Cenobamate will be orally administered once daily.
RECRUITING
Aichi Medical University Hospital, Aichi
RECRUITING
Hospital of the University of Occupational and Environmental Health, Japan, Fukuoka
RECRUITING
Southern TOHOKU Research Institute for Neuroscience Southern TOHOKU Medical Clinic, Fukushima
RECRUITING
Local Independent Administrative Corporation Hiroshima City Hospital Organization Hiroshima City Hiroshima Citizens Hospital, Hiroshima
RECRUITING
Hokkaido University Hospital, Hokkaido
RECRUITING
Itami City Hospital, Hyōgo
RECRUITING
Tsuchiura Kyodo General Hospita, Ibaraki
RECRUITING
University of Tsukuba Hospital, Ibaraki
RECRUITING
Kagoshima University Hospital, Kagoshima
RECRUITING
SHOWA University Fujigaoka Hospital, Kanagawa
RECRUITING
Yokohama City University Hospital, Kanagawa
RECRUITING
National Hospital Organization Nishiniigata Chuo Hospital, Niigata
RECRUITING
Koide Clinic of Epilepsy and Neurological Disorders, Osaka
RECRUITING
TMG Asaka Medical Center, Saitama
RECRUITING
NHO Shizuoka Institute of Epilepsy and Neurological Disorder, Shizuoka
RECRUITING
Jichi Medical University Hospital, Tochigi
RECRUITING
Jikei University Hospital, Tokyo
RECRUITING
Maynds Tower Mental Clinic, Tokyo
RECRUITING
National Center of Neurology and Psychiatry, Tokyo
RECRUITING
Nihonbashi Neuro Clinic, Tokyo
RECRUITING
Shinjuku Neuro Clinic, Tokyo
RECRUITING
Tokyo Women's Medical University, Adachi Medical Center, Tokyo
RECRUITING
Yamaguchi Grand Medical Center, Yamaguchi
RECRUITING
University of Yamanashi Hospital, Yamanashi
RECRUITING
Yamanashi Prefectural Central Hospital, Yamanashi
Lead Sponsor
Ono Pharmaceutical Co. Ltd
INDUSTRY